Published: 2015-02-25
Proceedings
The Evolving Landscape of GI Tumors
Abstract 93 | PDF Downloads 49Page 3
HER-2 and Gastric Cancer
Abstract 82 | PDF Downloads 49Page 5-7
Circulating tumor cells: current challenges and future perspectives
Abstract 96 | PDF Downloads 50Page 11-13
Update in localized rectal cancer
Abstract 70 | PDF Downloads 48Page 14-17
Therapeutic algorithm of pancreatic neuroendocrine neoplasms
Abstract 105 | PDF (Italian) Downloads 48Page 18-20
Neoadjuvant therapy of gastroesophageal junction adenocarcinoma: chemoradiotherapy or chemotherapy
Abstract 109 | PDF Downloads 47Page 21-23
Gastric Cancer: therapeutic choices in advanced disease
Abstract 83 | PDF Downloads 50Page 24-25
S-1 in the treatment of advanced gastric cancer: up-date
Abstract 130 | PDF Downloads 53Page 26-29
Ramucirumab: a new option in advanced gastric cancer
Abstract 83 | PDF Downloads 47Page 30-32
Bevacizumab beyond progression: Pros
Abstract 75 | PDF Downloads 54Page 33-35
The Challenge of anti-EGFR therapy-rechallenge in management of metastatic colorectal cancer
Abstract 121 | PDF Downloads 57Page 36-39
Second line treatment of metastatic colorectal cancer: aflibercept
Abstract 218 |Page 40-44
Resistance to biologic drugs
Abstract 86 | PDF Downloads 49Page 45-46
Monotherapy vs doublet chemotherapy vs Folfirinox: who and why
Abstract 87 | PDF Downloads 52Page 47-49
SPARC and treatment in pancreatic ductal adenocarcinoma: evidences and new challenge for the future
Abstract 107 | PDF Downloads 54Page 50-51
Update on nab-Paclitaxel in the treatment of pancreatic cancer
Abstract 94 | PDF Downloads 54Page 52-54